Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1979;57(Suppl):199–203.

Recent developments in vaccination against malaria: Immunization of experimental monkeys against Plasmodium falciparum: use of synthetic adjuvants*

W A Siddiqui, Diane W Taylor, S C Kan, K Kramer, S M Richmond-Crum, S Kotani, T Shiba, S Kasumoto
PMCID: PMC2395742  PMID: 120768

Abstract

The replacement of Freund's adjuvant by a possible safe adjuvant for effective immunization of owl monkeys (Aotus trivirgatus griseimembra) against a human malaria parasite, Plasmodium falciparum, has been investigated. Experiments involved the use of two synthetic adjuvants: MDP (N-acetylmuramyl-L-alanyl-D-isoglutamine) and stearoyl-MDP (6-O-stearoyl-N-acetylmuramyl-L-alanyl-D-isoglutamine). In both cases, P. falciparum merozoites obtained through short-term in vitro cultivation were used as antigen. MPD was used as adjuvant in 5 owl monkeys; 2 control monkeys died and of the 3 experimental monkeys only 1 survived. In contrast, in another experiment where stearoyl-MDP was used as adjuvant, there was 100% protection of 4 immunized monkeys against a challenge with the homologous strain of P. falciparum. The results of the second experiment are encouraging for the development of an effective and safe vaccine for human malaria.

Full text

PDF
199

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown K. N., Brown I. N., Hills L. A. Immunity to malaria. I. Protection against Plasmodium knowlesi shown by monkeys sensitized with drug-suppressed infections or by dead parasites in Freund's adjuvant. Exp Parasitol. 1970 Oct;28(2):304–317. doi: 10.1016/0014-4894(70)90101-3. [DOI] [PubMed] [Google Scholar]
  2. CUTLER J. C., LESESNE L., VAUGHN I. Use of poliomyelitis virus vaccine in light mineral oil adjuvant in a community immunization program and report of reactions encountered. J Allergy. 1962 May-Jun;33:193–209. doi: 10.1016/0021-8707(62)90086-2. [DOI] [PubMed] [Google Scholar]
  3. Holbrook T. W., Palczuk N. C., Stauber L. A. Immunity to exoerythrocytic forms of malaria. 3. Stage-specific immunization of turkeys against exoerythrocytic forms of Plasmodium fallax. J Parasitol. 1974 Apr;60(2):348–354. [PubMed] [Google Scholar]
  4. Inoue K. Permeability properties of liposomes prepared from dipalmitoyllecithin, dimyristoyllecithin, egg lecithin, rat liver lecithin and beef brain sphingomyelin. Biochim Biophys Acta. 1974 Mar 29;339(3):390–402. doi: 10.1016/0005-2736(74)90166-7. [DOI] [PubMed] [Google Scholar]
  5. Kotani S., Narita T., Stewart-Tull D. E., Shimono T., Watanabe Y. Immunoadjuvant activities of cell walls and their water-soluble fractions prepared from various gram-positive bacteria. Biken J. 1975 Jun;18(2):77–92. [PubMed] [Google Scholar]
  6. Mitchell G. H., Butcher G. A., Cohen S. A merozoite vaccine effective against Plasmodium knowlesi malaria. Nature. 1974 Nov 22;252(5481):311–313. doi: 10.1038/252311a0. [DOI] [PubMed] [Google Scholar]
  7. Mitchell G. H., Richards W. H., Butcher G. A., Cohen S. Merozoite vaccination of douroucouli monkeys against falciparum malaria. Lancet. 1977 Jun 25;1(8026):1335–1338. doi: 10.1016/s0140-6736(77)92551-x. [DOI] [PubMed] [Google Scholar]
  8. Schenkel R. H., Simpson G. L., Silverman P. H. Vaccination of Rhesus monkeys (Macaca mulatta) against Plasmodium knowlesi by the use of nonviable antigen. Bull World Health Organ. 1973 May;48(5):597–604. [PMC free article] [PubMed] [Google Scholar]
  9. Siddiqui W. A., Kramer K., Richard-Crum S. M. In vitro cultivation and partial purification of Plasmodium falciparum antigen suitable for vaccination studies in Aotus monkeys. J Parasitol. 1978 Feb;64(1):168–169. [PubMed] [Google Scholar]
  10. Siddiqui W. A., Richmond-Crum S. M. Fatty acid-free bovine albumin as plasma replacement for in vitro cultivation of Plasmodium falciparum. J Parasitol. 1977 Jun;63(3):583–584. [PubMed] [Google Scholar]
  11. Simpson G. L., Schenkel R. H., Silverman P. H. Vaccination of rhesus monkeys against malaria by use of sucrose density gradient fractions of Plasmodium knowlesi antigens. Nature. 1974 Feb 1;247(5439):304–305. doi: 10.1038/247304a0. [DOI] [PubMed] [Google Scholar]
  12. Voller A., Richards W. H. An attempt to vaccinate owl monkeys (Aotus trivirgatus) against falciparum malaria. Lancet. 1968 Nov 30;2(7579):1172–1174. doi: 10.1016/s0140-6736(68)91644-9. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES